Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Assets (2016 - 2025)

Bruker (BRKR) has disclosed Assets for 16 consecutive years, with $6.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets rose 7.49% year-over-year to $6.2 billion, compared with a TTM value of $6.2 billion through Dec 2025, up 7.49%, and an annual FY2025 reading of $6.2 billion, up 7.49% over the prior year.
  • Assets was $6.2 billion for Q4 2025 at Bruker, down from $6.4 billion in the prior quarter.
  • Across five years, Assets topped out at $6.4 billion in Q3 2025 and bottomed at $3.0 billion in Q1 2021.
  • Average Assets over 5 years is $4.5 billion, with a median of $3.8 billion recorded in 2023.
  • The sharpest move saw Assets fell 1.05% in 2022, then soared 60.04% in 2024.
  • Year by year, Assets stood at $3.6 billion in 2021, then dropped by 1.05% to $3.6 billion in 2022, then increased by 17.67% to $4.2 billion in 2023, then skyrocketed by 36.63% to $5.8 billion in 2024, then grew by 7.49% to $6.2 billion in 2025.
  • Business Quant data shows Assets for BRKR at $6.2 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.3 billion in Q2 2025.